08May 2024
Clinical Outcomes of Topical Bevacizumab for the Treatment of Corneal Neovascularization

Clinical Outcomes of Topical Bevacizumab for the Treatment of Corneal Neovascularization

A recent study assessed the efficacy of topical bevacizumab in treating corneal neovascularization, where abnormal blood vessels invade the cornea. Sixteen patients underwent treatment over three years, with 12 meeting inclusion criteria. Notably, 66% showed improvement, especially in cases of infective causes. While bevacizumab appears promising for mild to moderate cases, its efficacy in chronic instances remains uncertain. Individualized treatment strategies are crucial due to varied outcomes based on condition severity. Thus, while bevacizumab shows potential, further research is needed to determine its role in managing corneal neovascularization.

  • #ophthalmology

Like

Save

Share